-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Northwest Biotherapeutics Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q1 2024.
- Northwest Biotherapeutics Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$12.4M, a 10.4% decline year-over-year.
- Northwest Biotherapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$53.6M, a 1.63% decline from 2022.
- Northwest Biotherapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$52.8M, a 37.8% decline from 2021.
- Northwest Biotherapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$38.3M, a 19.3% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)